Resources | NITAG RESOURCE CENTER

2024 ∙ NACI

Guidance on an additional dose of COVID-19 vaccines in the spring for individuals at high risk of severe illness due to COVID-19

2023 ∙ Masaquel, C. Schley, K. Wright, K. Mauskopf, J. Parrish, R. A. Presa, J. V. Hewlett, D.

The Impact of Social Determinants of Health on Meningococcal Vaccination Awareness, Delivery, and Coverage in Adolescents and Young Adults in the United States: A Systematic Review

2023 ∙ Matthew Tunis, Shelley Deeks, Caroline Quach, Marina Salvadori, Bryna Warshawsky, Kelsey Young, Shainoor Ismail, Christine Mauviel, Erin Henry

Canada’s National Advisory Committee on immunization: Adaptations and challenges during the COVID-19 pandemic

2023 ∙ NACI

Updated guidance on the use of COVID-19 vaccines in individuals who have not previously been vaccinated against COVID-19

2023 ∙ ACIP

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023–24 Influenza Season

2023 ∙ NACI, Anne Pham-Huy, Joseline Zafack, Courtney Primeau, Oliver Baclic, Marina Salvadori, Shelley Deeks

A National Advisory Committee on Immunization (NACI) update on invasive meningococcal disease (IMD) epidemiology and program-relevant considerations for preventing IMD in individuals at high risk of exposure

2023 ∙ ACIP

Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices

2023 ∙ ACIP

Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices

2023 ∙ ACIP

Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months — United States, April 2023

2023 ∙ NACI

Guidance on the use of COVID-19 vaccines in the fall of 2023